CPT® Code 0265T

Intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one leg, including ultrasound guidance, if performed; unilateral or bilateral bone marrow harvest only for intramuscular autologous bone marrow cell therapy

Intramuscular autologous bone marrow cell therapy is a specialized medical procedure designed to treat patients suffering from peripheral artery disease (PAD), particularly in cases where severe limb ischemia poses a significant risk of amputation. This therapy involves the collection and preparation of the patient's own bone marrow cells, which are then injected into the affected areas of the leg to promote healing and improve blood flow. The procedure begins with the harvesting of bone marrow, typically from the iliac crest, using a bone marrow needle. This harvested bone marrow is then processed to concentrate the viable cells, which are subsequently re-injected into the ischemic regions of the leg, often guided by ultrasound to ensure precise placement. Prior to the bone marrow harvest, diagnostic procedures such as Doppler-guided arterial segment pressures and routine angiography may be performed to assess the vascular condition and identify any stenosis or occlusions. The overall goal of this therapy is to enhance circulation and alleviate symptoms associated with PAD, thereby potentially reducing the need for more invasive surgical interventions.